Related Experiment Video
Updated: Aug 1, 2026
06:09
Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates
Published on: May 30, 2025
Who is using cannabis as a medicine and why: an exploratory study
A C Ogborne1, R G Smart, T Weber
1Centre for Addiction and Mental Health, London, Ontario, Canada. ogborne@julian.uwo.ca
Journal of Psychoactive Drugs
|February 24, 2001
Summary
Medical cannabis is used for diverse conditions, with many users also engaging in recreational use. This study explores user experiences and doctor interactions, highlighting the need for clearer definitions and policies.
Area of Science:
- Medical Cannabis Research
- Patient-Reported Outcomes
- Cannabis Use Patterns
Background:
- Growing interest in medical cannabis for various conditions.
- Limited understanding of self-identified medical cannabis users' experiences.
- Need to explore the intersection of medical and recreational cannabis use.
Purpose of the Study:
- To conduct an exploratory study of self-identified medical cannabis users.
- To understand the conditions for which cannabis is used medically.
- To investigate user experiences, including concurrent recreational use and doctor interactions.
Main Methods:
- Exploratory study involving interviews with 50 self-identified medical cannabis users.
- Participants recruited via newspaper and bulletin board notices.
- Qualitative data collection on usage patterns, conditions treated, and experiences.
Main Results:
- Users reported cannabis for conditions like chronic pain, anxiety, depression, and HIV-AIDS-related issues.
- A majority also used cannabis recreationally; many were long-term users.
- Most participants smoked cannabis multiple times daily; few reported negative experiences.
- Doctor interactions ranged from noncommittal to supportive.
Conclusions:
- Findings challenge the definition of medical cannabis use.
- Results suggest a need for policies accommodating diverse cannabis use patterns.
- Further research with larger, representative samples is recommended, particularly for specific populations like those with HIV-AIDS.
Related Concept Videos
02:43Mouse Models of Cancer Study
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...